New drugs are urgently needed to combat the growing threat of high-resistance bacteria, but few are in the pipeline. What is happening? In a time when great new pharmaceutical products cure some of our most deadly diseases and help us live healthier lives, the world has largely abandoned the development of some of the most needed drugs of modern medicine antibiotics.
Between the times it was discovered penicillin in 1928 and the 1970s, antibiotics 270 a solid arsenal of powerful drugs that kept at bay bacteria as almost all infections were approved. But since then, research on new antibiotics has drastically declined. The last set of truly new antibiotics to be approved was discovered more than 30 years ago says microbiologist Carolyn Shore, a Pew Charitable Trusts Project Officer on Antibiotic Resistance. At present, only five of the fifty major large pharmaceutical companies are developing new antibiotics. Continue reading “What’s happening with antibiotics?”